Skip to main content
Premium Trial:

Request an Annual Quote

David Mittelman

Tute Genomics has hired David Mittelman as its chief scientific officer. He joins the company from Arpeggi, a bioinformatics company he co-founded that was acquired by Gene by Gene in 2013. Previously he was an associate professor at Virginia Tech. Mittelman has a PhD in molecular biophysics from Baylor College of Medicine and completed his postdoctoral training at Baylor’s Human Genome Sequencing Center.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.